¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymphocyte mitogenic factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mitogenic factor
ºÐ¿ÃËÁøÀÎÀÚ
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
atypical lymphocyte
ºñÁ¤Çü¸²ÇÁ±¸
effector lymphocyte
È¿°ú¸²ÇÁ±¸
killer lymphocyte
»ìÇØ¸²ÇÁ±¸, ¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
lymphocyte series
¸²ÇÁ±¸°è¿
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤ÀÎÀÚ
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte
ÃÊȸ¹Î°¨¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸ¹Î°¨¸²ÇÁ±¸Çü°áÁ¤
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mixed lymphocyte culture
È¥ÇÕ¸²ÇÁ±¸¹è¾ç
lymphocyte
¸²ÇÁ±¸
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
coagulation V factor
Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
exclusion of confounding factor
±³¶õº¯¼ö¹èÁ¦
growth factor
¼ºÀåÀÎÀÚ
intrinsic factor
³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mitogenic factor
ºÐ¿ÃËÁøÀÎÀÚ
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte inhibitory factor
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
atypical lymphocyte
ºñÀüÇü¸²ÇÁ±¸
lymphocyte-activating determinant
¸²ÇÁ±¸È°¼º°áÁ¤±â
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸
killer lymphocyte
¼¼Æ÷µ¶¼º¸²ÇÁ±¸
lymphocyte
¸²ÇÁ±¸
leukocytoid lymphocyte
¹éÇ÷±¸¸ð¾ç¸²ÇÁ±¸
lymphocyte series
¸²ÇÁ±¸°è¿
primed lymphocyte
ÃÊȸ¹Î°¨¸²ÇÁ±¸
resident lymphocyte
»óÁÖ¸²ÇÁ±¸
reticular lymphocyte
¸Á»ó¸²ÇÁ±¸
sensitized lymphocyte
¹Î°¨¸²ÇÁ±¸
short lived lymphocyte
´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
F factor (fertility factor)
FÀÎÀÚ, ¼öÅÂÀÎÀÚ
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B lymphocyte
B ¸²ÇÁ±¸
B-lymphocyte
B ¸²ÇÁ±¸.
Bare lymphocyte syndrome
¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
mitogenic factor
ºÐ¿À¯¹ß¼º ÀÎÀÚ.
mitogenic factor
ºÐ¿ÃËÁøÀÎÀÚ.
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte activating factor (LAF)
¸²ÇÁ±¸ Ȱ¼ºÈÀÎÀÚ
lymphocyte inhibitory factor (LIF)
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte-derived chemotactic factor
¸²ÇÁ±¸À¯·¡ ÈÇÐÁÖ¼ºÀÎÀÚ
col factor(»ýÈ) cÀÌ ÀÎÀÚ colicin factor
Äݸ®½ÅÀÎÀÚ.
lupus erythematosus factor = LE factor
È«¹Ý¼º ·çǪ½ºÀÎÀÚ(ûõÚèàõ¡ì×í)
time, dose and fractionation factor, TDF factor
½Ã°£¼±·®ºÐÇÒÀÎÀÚ
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
atypical lymphocyte
ÀÌÇü<ºñÁ¤Çü>¸²ÇÁ±¸(?Ë´).
cytotoxic T lymphocyte (CTL)
¼¼Æ÷µ¶¼ºT¸²ÇÁ±¸
effector T lymphocyte
ÀÛµ¿T¸²ÇÁ±¸
effector lymphocyte
ÀÛµ¿¸²ÇÁ±¸.
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½